3983 — China BlueChemical Cashflow Statement
0.000.00%
- HK$12.91bn
- HK$574.77m
- CNY12.03bn
Annual cashflow statement for China BlueChemical, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | C2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | — |
| Source: | ARS | ARS | ARS | ARS | |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | fx Preliminary |
| Net Income/Starting Line | 2,642 | 2,271 | 2,664 | 1,467 | — |
| Depreciation | |||||
| Non-Cash Items | -591 | -372 | -1,197 | -438 | — |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 331 | -323 | -550 | -173 | — |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 2,939 | 2,142 | 1,544 | 1,523 | — |
| Capital Expenditures | -1,080 | -1,339 | -743 | -605 | — |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -2,583 | -1,006 | 51.8 | 226 | — |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -3,663 | -2,345 | -691 | -379 | — |
| Financing Cash Flow Items | -64.5 | -248 | 12.2 | -139 | — |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -1,367 | 56.4 | -784 | -1,061 | — |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -2,091 | -146 | 68.5 | 82.7 | — |